Our Corporate Mergers and Acquisition Team advised Pathcare Nigeria Limited in its recent corporate restructuring and acquisition of majority stake by Synlab Suisse SA., a global medical diagnostic service provider.

Pathcare Nigeria Limited a market leader in the field of human laboratory diagnostics operates six laboratories and twenty-one blood collection points across Nigeria.  It has a special focus on public-private partnerships and a strong market position based on its high-quality service, the breadth of its test portfolio, and its nationwide network.

To facilitate the Synlab deal, our firm advised PathCare Nigeria Limited on the divestment of 26 percent stake held by PathCare South Africa.  The recent acquisition will see PathCare Nigeria Limited’s customers benefiting from an enhanced and extended portfolio of specialised tests drawing from the breadth and depth of Synlab’s international expertise.  It is also expected that the investment will have a positive impact on healthcare development in the Country and reduce medical tourism offshore.

The JEE team was led by Partner: Folasade Olusanya, Senior Associates Kunle Soyibo, Kingsley Opia-Enwemuche and Yeye Nwidaa and Associates Adetola Adeleye and Ekiomado Ewere-Isaiah.

Folasade Olusanya, Partner, JEE commented:

“The Firm as part of Pathcare Nigeria Limited’s initial growth strategy is pleased to have played a significant role in this landmark acquisition in the healthcare sector.

The transaction had 4 subsets and with significant effort, we undertook to deliver all the sub-transactions at the same time to ensure the closing of the ultimate transaction.  We also had to deal with sensitivities of promoter shareholders and the commercial aspect of introducing a new partner into the business”

JEE has extensive experience in complex corporate restructuring, mergers & acquisitions and cross-border acquisitions. Our Mergers & Acquisitions Practice is recognized and ranked in various legal directories and journals such as; International Financial Law Review 1000 (IFLR1000), Chambers & Partners Global Review; and Legal 500. Our lawyers have also been recognized in these directories for their expertise in Mergers & Acquisitions.